NEW YORK (GenomeWeb News) – GE today said that it has named Sue Siegel, a former president of Affymetrix, to serve as CEO of its healthymagination initiative.

Siegel joins GE from Mohr Davidow Ventures, where she was a general partner leading investments in technology paltforms such as molecular diagnostics and digital health. She takes over the CEO role from Mike Barber, who led the initiative since 2009 but has been named VP and general manager of molecular imaging at GE Healthcare.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.